Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Identifieur interne : 000669 ( PubMed/Checkpoint ); précédent : 000668; suivant : 000670Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
Auteurs : Shirley Owusu-Ofori [Ghana] ; Jillian Temple ; Francis Sarkodie ; Margaret Anokwa ; Daniel Candotti ; Jean-Pierre AllainSource :
- Transfusion [ 0041-1132 ] ; 2005.
Descripteurs français
- KwdFr :
- ADN viral (analyse), Donneurs de sang, Dépistage systématique (), Facteurs de risque, Ghana (épidémiologie), Humains, Hépatite B (), Hépatite B (transmission), Hépatite B (épidémiologie), Hépatite C (), Hépatite C (transmission), Hépatite C (épidémiologie), Infections à VIH (), Infections à VIH (transmission), Infections à VIH (épidémiologie), Maladies virales (), Maladies virales (transmission), Maladies virales (épidémiologie), Pathogènes transmissibles par le sang (isolement et purification), Pays en voie de développement, Prévalence, Techniques immunoenzymatiques.
- MESH :
- analyse : ADN viral.
- isolement et purification : Pathogènes transmissibles par le sang.
- épidémiologie : Ghana, Hépatite B, Hépatite C, Infections à VIH, Maladies virales.
- Donneurs de sang, Dépistage systématique, Facteurs de risque, Humains, Hépatite B, Hépatite C, Infections à VIH, Maladies virales, Pays en voie de développement, Prévalence, Techniques immunoenzymatiques.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Blood Donors, Blood-Borne Pathogens (isolation & purification), DNA, Viral (analysis), Developing Countries, Ghana (epidemiology), HIV Infections (epidemiology), HIV Infections (prevention & control), HIV Infections (transmission), Hepatitis B (epidemiology), Hepatitis B (prevention & control), Hepatitis B (transmission), Hepatitis C (epidemiology), Hepatitis C (prevention & control), Hepatitis C (transmission), Humans, Immunoenzyme Techniques, Mass Screening (methods), Prevalence, Risk Factors, Virus Diseases (epidemiology), Virus Diseases (prevention & control), Virus Diseases (transmission).
- MESH :
- chemical , analysis : DNA, Viral.
- geographic , epidemiology : Ghana.
- epidemiology : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- isolation & purification : Blood-Borne Pathogens.
- methods : Mass Screening.
- prevention & control : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- transmission : HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- Blood Donors, Developing Countries, Humans, Immunoenzyme Techniques, Prevalence, Risk Factors.
Abstract
In sub-Saharan Africa, the percentage of screened blood is limited to approximately 75 percent for human immunodeficiency virus antibodies (anti-HIV), 50 percent for hepatitis B surface antigen, and 19 percent for hepatitis C virus antibodies (anti-HCV), mainly because of costs.
DOI: 10.1111/j.1537-2995.2004.04279.x
PubMed: 15660820
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15660820Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.</title><author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name></author><author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name></author><author><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name></author><author><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name></author><author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15660820</idno><idno type="pmid">15660820</idno><idno type="doi">10.1111/j.1537-2995.2004.04279.x</idno><idno type="wicri:Area/PubMed/Corpus">000680</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000680</idno><idno type="wicri:Area/PubMed/Curation">000680</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000680</idno><idno type="wicri:Area/PubMed/Checkpoint">000680</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000680</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.</title><author><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name></author><author><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name></author><author><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name></author><author><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name></author><author><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name></author></analytic><series><title level="j">Transfusion</title><idno type="ISSN">0041-1132</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Donors</term><term>Blood-Borne Pathogens (isolation & purification)</term><term>DNA, Viral (analysis)</term><term>Developing Countries</term><term>Ghana (epidemiology)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Hepatitis B (epidemiology)</term><term>Hepatitis B (prevention & control)</term><term>Hepatitis B (transmission)</term><term>Hepatitis C (epidemiology)</term><term>Hepatitis C (prevention & control)</term><term>Hepatitis C (transmission)</term><term>Humans</term><term>Immunoenzyme Techniques</term><term>Mass Screening (methods)</term><term>Prevalence</term><term>Risk Factors</term><term>Virus Diseases (epidemiology)</term><term>Virus Diseases (prevention & control)</term><term>Virus Diseases (transmission)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ADN viral (analyse)</term><term>Donneurs de sang</term><term>Dépistage systématique ()</term><term>Facteurs de risque</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Hépatite B ()</term><term>Hépatite B (transmission)</term><term>Hépatite B (épidémiologie)</term><term>Hépatite C ()</term><term>Hépatite C (transmission)</term><term>Hépatite C (épidémiologie)</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Infections à VIH (épidémiologie)</term><term>Maladies virales ()</term><term>Maladies virales (transmission)</term><term>Maladies virales (épidémiologie)</term><term>Pathogènes transmissibles par le sang (isolement et purification)</term><term>Pays en voie de développement</term><term>Prévalence</term><term>Techniques immunoenzymatiques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>DNA, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>ADN viral</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Blood-Borne Pathogens</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Pathogènes transmissibles par le sang</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term><term>Hepatitis C</term><term>Virus Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Hépatite B</term><term>Hépatite C</term><term>Infections à VIH</term><term>Maladies virales</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blood Donors</term><term>Developing Countries</term><term>Humans</term><term>Immunoenzyme Techniques</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Donneurs de sang</term><term>Dépistage systématique</term><term>Facteurs de risque</term><term>Humains</term><term>Hépatite B</term><term>Hépatite C</term><term>Infections à VIH</term><term>Maladies virales</term><term>Pays en voie de développement</term><term>Prévalence</term><term>Techniques immunoenzymatiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In sub-Saharan Africa, the percentage of screened blood is limited to approximately 75 percent for human immunodeficiency virus antibodies (anti-HIV), 50 percent for hepatitis B surface antigen, and 19 percent for hepatitis C virus antibodies (anti-HCV), mainly because of costs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15660820</PMID><DateCreated><Year>2005</Year><Month>01</Month><Day>21</Day></DateCreated><DateCompleted><Year>2005</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0041-1132</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2005</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.</ArticleTitle><Pagination><MedlinePgn>133-40</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In sub-Saharan Africa, the percentage of screened blood is limited to approximately 75 percent for human immunodeficiency virus antibodies (anti-HIV), 50 percent for hepatitis B surface antigen, and 19 percent for hepatitis C virus antibodies (anti-HCV), mainly because of costs.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">In 2002 to 2003, candidate blood donors were screened before donation for HIV, HCV, and hepatitis B virus (HBV) serologic markers with rapid tests. The efficacy of this screening was assessed by nucleic acid testing (NAT) applied to pools of 10 plasma samples from donated units with a virus specific triplex assay. NAT-reactive pools were resolved by viral genome identification in individual plasma sample. Deferred candidate donors were referred to a donor-care program.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 9372 people were screened and 1534 (16.4%) were deferred. No HIV or HCV RNA-containing samples remained undetected by rapid tests unless a human testing error was involved. In contrast, 1.3 and 3.0 percent of HBV DNA-containing blood units were negative with rapid tests but were detected in individual donations with enzyme immunoassay and genomic amplification, respectively. Only half of these units were detectable in pools of 10 samples. One-third of deferred candidate donors attended the donor-care program and were informed and counseled.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Predonation viral screening of blood donors is effective in high endemic areas, and the savings it generates may improve the safety and limit the cost of blood. Communication with deferred donors may contribute to public health. A new screening strategy associating serologic rapid test before donation and NAT on pools of 10 plasma samples after donation is proposed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Owusu-Ofori</LastName><ForeName>Shirley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temple</LastName><ForeName>Jillian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sarkodie</LastName><ForeName>Francis</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Anokwa</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Candotti</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Transfusion. 2005 Feb;45(2):130-2</RefSource><PMID Version="1">15660819</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="Y">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017848" MajorTopicYN="N">Blood-Borne Pathogens</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004279" MajorTopicYN="N">DNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>8</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15660820</ArticleId><ArticleId IdType="pii">TRF04279</ArticleId><ArticleId IdType="doi">10.1111/j.1537-2995.2004.04279.x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country></list><tree><noCountry><name sortKey="Allain, Jean Pierre" sort="Allain, Jean Pierre" uniqKey="Allain J" first="Jean-Pierre" last="Allain">Jean-Pierre Allain</name><name sortKey="Anokwa, Margaret" sort="Anokwa, Margaret" uniqKey="Anokwa M" first="Margaret" last="Anokwa">Margaret Anokwa</name><name sortKey="Candotti, Daniel" sort="Candotti, Daniel" uniqKey="Candotti D" first="Daniel" last="Candotti">Daniel Candotti</name><name sortKey="Sarkodie, Francis" sort="Sarkodie, Francis" uniqKey="Sarkodie F" first="Francis" last="Sarkodie">Francis Sarkodie</name><name sortKey="Temple, Jillian" sort="Temple, Jillian" uniqKey="Temple J" first="Jillian" last="Temple">Jillian Temple</name></noCountry><country name="Ghana"><noRegion><name sortKey="Owusu Ofori, Shirley" sort="Owusu Ofori, Shirley" uniqKey="Owusu Ofori S" first="Shirley" last="Owusu-Ofori">Shirley Owusu-Ofori</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000669 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000669 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15660820
|texte= Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15660820" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |